Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
3SBio ( (HK:1530) ) has provided an announcement.
3SBio, a company incorporated in the Cayman Islands, has successfully completed the subscription of new shares under a general mandate, issuing 31,142,500 shares to Pfizer at a price of HK$25.2055 per share. This transaction, which represents a 1.28% increase in the company’s share capital, raised approximately HK$785 million in net proceeds. The funds will be allocated primarily to global R&D initiatives and enhancing manufacturing facilities, with a portion reserved for general corporate purposes.
The most recent analyst rating on (HK:1530) stock is a Buy with a HK$30.00 price target. To see the full list of analyst forecasts on 3SBio stock, see the HK:1530 Stock Forecast page.
More about 3SBio
Average Trading Volume: 54,791,132
Technical Sentiment Signal: Buy
Current Market Cap: HK$77.08B
For an in-depth examination of 1530 stock, go to TipRanks’ Overview page.